Bayani
Matsakaicin mu na Omeprazole 2.3.5-Trimethyl-4-nitropyridine-N-oxide an ƙera shi a hankali don saduwa da mafi girman matsayin masana'antu, yana tabbatar da tsabtarsa da ingancinsa kuma ana iya amfani dashi a cikin nau'ikan sinadarai da magunguna.Tare da madaidaicin abun da ke ciki da ingantaccen ingancinsa, wannan fili shine cikakken zaɓi ga masu bincike, masana kimiyya da ƙwararrun magunguna waɗanda ke neman abin dogaro, matsakaicin matsakaici don ayyukansu.
Wannan tsaka-tsakin yana taka muhimmiyar rawa wajen samar da omeprazole, maganin da ake amfani da shi sosai don magance cututtuka masu alaka da acid kamar cututtukan gastroesophageal reflux (GERD), ulcers, da zolin (Guardian-Ellison syndrome).A matsayin maɓalli mai mahimmanci a cikin haɗin omeprazole, matsakaicin omeprazole namu na 2.3.5-trimethyl-4-nitropyridine-N-oxide yana sauƙaƙe samar da inganci da farashi mai mahimmanci na wannan mahimmancin magunguna.
Zaba Mu
JDK ya mallaki wuraren samar da ajin farko da na'urorin sarrafa inganci, wanda ke tabbatar da tsayayyen samar da matsakaicin API.Ƙwararrun ƙungiyar sun tabbatar da R&D na samfurin.A kan duka biyun, muna neman CMO & CDMO a cikin gida da kasuwannin duniya.
![Tofacitinib Intermediate (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid da (3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidine amine CAS No. 477600 -71-8](http://cdn.globalso.com/jdkhc/2R-3R-23-bis-4-methylbenzoyl-oxy-succinic-acid-and-3R-4R-N-4-dimethyl-1-phenylmethyl-3-piperidine-amine.jpg)
